News

People suffering from arthritis will soon have a new over-the-counter treatment option. Voltaren Arthritis Pain, a non-steroidal anti-inflammatory topical gel, has been approved for over-the-counter ...
WARREN, N.J., May 3, 2021 /PRNewswire/ — GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers a ...
Your joints are often one of the first places you'll feel your age. Just getting out of bed each morning can produce a chorus of cracks and a symphony of soreness, and rather than reaching for a ...
Warren-based GlaxoSmithKline announced on Monday the U.S. Food and Drug Administration (FDA) approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent arthritis pain reliever) as an ...
The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...
WARREN, N.J., Feb. 17, 2020 /PRNewswire/ -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium ...